In This Review:
Reviewed by The Supplement Post Editorial Team, Editorial Review
Updated
1. Program at a Glance
| Product | HumeCare+ |
| Category | GLP-1 Weight Loss / Prescription Telehealth / Compounded Semaglutide & Tirzepatide |
| Access | A free online evaluation, then a licensed U.S. clinician decides whether to prescribe — approval is not guaranteed |
| What's Included | Compounded GLP-1 medication (injectable or oral semaglutide, or tirzepatide) + Hume Pod smart scale + app-based dose tracking; B12 and glycine added on the tirzepatide plan |
| Who Provides It | Hume Health Care LLC (a technology and administrative platform) + an independent Clinical Network of licensed U.S. prescribers; compounded at licensed U.S. pharmacies |
| Availability | 46 states + Washington, D.C. (not Alabama, Arkansas, Louisiana or Mississippi); self-pay only — no insurance, Medicare or Medicaid |
| Guarantee | 90-Day Weight Loss Results Guarantee, first-time GLP-1 users who meet all program conditions (full terms in §7) |
| Our Rating | 4.6 / 5 |
Quick Verdict
Does the HumeCare+ GLP-1 subscription work for weight loss? The medication behind it does, and the evidence is unusually strong for this category: in the STEP 1 trial, published in the New England Journal of Medicine, semaglutide averaged about 15% of body weight lost; tirzepatide reached 21% in SURMOUNT-1. What HumeCare+ adds isn't a new molecule — it's access to one. A licensed U.S. clinician reviews your free assessment and decides whether to prescribe, and if you're approved the medication ships monthly with a Hume Pod smart scale and 24/7 clinical support, for $199 or $299 a month — roughly a third of what the brand-name injectables cost in cash.
Two honest caveats, because they’re the whole reason to read past this box. Those trials tested the brand-name drug; what ships here is a compounded version, which the FDA has not reviewed for safety or efficacy — the distinction is real, and §2 explains it. And approval is a genuine gate, not a formality: a clinician can decline. There’s also a consultation fee the site never publishes, and a results guarantee written three different ways across their own pages — §7 has the version that actually binds.
2. Prescription GLP-1 Access: Evidence, Concerns & Trends
Three questions people ask before they trust a service like this one.
| What people wonder | What the evidence shows | What it means for you |
|---|---|---|
| "Does this class of drug actually work, or am I paying for hope?" | It works, and the numbers are unusually large for weight loss. In the STEP 1 trial, published in the New England Journal of Medicine, people on semaglutide lost about 15% of their body weight over roughly a year and a half. The SURMOUNT-1 trial, in the same journal, reached 21% on the highest dose of tirzepatide. | Whether the medicine works was settled years ago. What kept most people out was never the science — it was a price insurance rarely covers for weight loss, and finding a doctor who would write it. |
| "Is 'compounded' the same thing as the real drug?" | No, and the FDA says so plainly: compounded GLP-1 medicines "are not FDA-approved and have not been reviewed by the FDA for safety, efficacy, or manufacturing quality." The trials above tested the brand-name version. | Take that seriously — it's the single biggest difference between this and a pharmacy prescription. It's also why who compounds it matters: a named clinical network and a licensed U.S. pharmacy are not the same as a website with no address. |
| "Will I lose muscle along with the fat?" | Some of it, yes. Two 2024 reviews — one in Diabetes, Obesity and Metabolism, one in The Lancet Diabetes & Endocrinology — both flag lean-tissue loss as a known trade-off of losing weight this fast. | It's a manageable one. Keep protein up and keep moving — and it's why the tirzepatide plan here adds B12 and glycine rather than sending the medication alone. |
Where HumeCare+ fits: on the access side of a drug class that already has strong trial data behind it. It doesn't need to prove semaglutide or tirzepatide work — STEP 1 and SURMOUNT-1 did that. What it has to earn is trust in the process: a real evaluation, a real pharmacy, and honest terms. Here's the label reality.
3. What HumeCare+ Does and Includes
About 4 in 10 U.S. adults live with obesity, per the CDC, and most of them have already tried the standard advice: eat less, move more, wait. For a lot of people, that advice was never the missing piece — appetite regulation is. GLP-1, the hormone semaglutide and tirzepatide mimic, is what tells your brain you're full and slows how fast your stomach empties. Some people make less of it, or their body stops responding to it as well as it used to, and no amount of willpower changes that.
HumeCare+ doesn't sell willpower. It's a telehealth membership built to get a real prescription in front of you: an online intake questionnaire, a licensed U.S. clinician's evaluation, and — if approved — compounded semaglutide (injectable or oral) or compounded tirzepatide with added B12 and glycine, shipped to your door along with a Hume Pod smart scale and an app that logs every dose.
"Compounded" is the word worth sitting with. It means a licensed pharmacy prepares the medication to your prescription — standard practice for a drug in short supply or needing a custom dose — rather than the pre-filled Ozempic or Wegovy pen from Novo Nordisk. The FDA hasn't reviewed the compounded version for safety, efficacy or manufacturing quality the way it has the brand, and HumeCare+'s own Terms say so in capital letters. That's a real trade-off attached to a real price difference, and it deserves to be said plainly instead of buried under "clinically proven."
What you're actually buying is access: a legitimate clinical evaluation, a real prescription pathway if you qualify, and ongoing monitoring, for a fraction of what the injectable brand name costs in cash. Whether you get prescribed anything is up to the Clinical Network reviewing your case — Hume itself says it doesn't guarantee a prescription. What follows is the honest version: what ships, what the evidence behind the drug class actually shows, and what the guarantee will and won't cover.
4. Why We Rate It 4.6 / 5
HumeCare+ gets you real prescription-grade GLP-1 medication and genuine clinical oversight — the strongest access path in this category — but its own marketing muddies a good offer with three conflicting guarantee claims and a consultation fee it never prints.
What stands out:
- Real prescription medication, not a mimetic — compounded semaglutide or tirzepatide, prescribed after an actual clinical evaluation, not an over-the-counter stand-in
- The drug class has real trial data behind it — STEP 1 and SURMOUNT-1 are the large randomized trials that established semaglutide and tirzepatide work for weight loss
- The tirzepatide plan adds B12 and glycine — aimed at the muscle-loss trade-off the GLP-1 research flags, alongside the medication itself
- App and Hume Pod smart scale included — dose logging and body-composition tracking that also double as the guarantee's own paper trail
- Cancel anytime, no long-term contract — 48 hours' notice before the next billing date is all it takes
- Self-pay pricing well under the injectable brand names — $199 or $299 a month against a list price most insurance won't cover for weight loss alone
Where it falls short:
- The guarantee's real terms are stricter than the homepage suggests — first-time GLP-1 users only, zero missed doses, 13 weekly Hume Pod weigh-ins, and a 14-day claim window (the Terms of Service, not the "lose 10% or refund" banner, is the version that governs)
- An enrollment and refill consultation fee applies and isn't published anywhere — confirm the amount at checkout before you commit
- Self-pay only, and not everywhere — no insurance, Medicare or Medicaid, and unavailable in Alabama, Arkansas, Louisiana or Mississippi
- Approval isn't guaranteed — Hume says plainly it doesn't promise you'll be prescribed anything, so the evaluation can end without a prescription
Full scorecard across all 6 criteria: HumeCare+ Scorecard →
5. Who Is HumeCare+ Best For?
Best match if you:
- Have a BMI of 27+ and want prescription-strength GLP-1 medication without paying the injectable brand-name's list price in cash
- Have never used a GLP-1 drug before — that's also who the 90-day results guarantee is actually built for
- Live in one of the 46 states (or D.C.) HumeCare+ currently serves, and can pay out of pocket — insurance, Medicare and Medicaid aren't accepted
- Want a licensed clinician reviewing your case, not a compounding pharmacy you found on your own
- Will actually use the Hume Pod and log every dose — the app tracking is also what the guarantee requires
Look at alternatives if you:
- Have already used any GLP-1 medication, compounded or brand-name — you won’t qualify for the results guarantee, and possibly not for enrollment
- Live in Alabama, Arkansas, Louisiana or Mississippi
- Would rather try a non-prescription route first — our GLP-1 Plus review covers a supplement built around raising your own GLP-1 instead
- Need insurance to cover the cost, since HumeCare+ is self-pay only
6. How It Compares
The "natural GLP-1 support" aisle and an actual prescription for the hormone's own drug class are two different tools aimed at the same appetite problem, and it's worth seeing them side by side before picking a lane.
| Criteria | HumeCare+ (this review) | GLP-1 Plus | MounjaBoost |
|---|---|---|---|
 |
 |
 |
|
| Primary route | Prescription compounded semaglutide or tirzepatide | Dihydroberberine / AMPK — raises your own GLP-1 | Pink salt & Korean turmeric metabolism drops |
| Access | Online clinical evaluation & prescription required | No prescription needed | No prescription needed |
| Best suited to | BMI 27+, wants drug-class-level results | Cravings & blood-sugar swings, no injection wanted | A lower-commitment metabolism nudge |
| Format | Monthly telehealth subscription, injectable or oral Rx | Capsule | Liquid drops |
| Monthly cost | $199–$299 | ~$67–$80 (30-day bottle) | ~$49–$79 (30-day bottle) |
| Where to buy | Official Site → | Official Site → | Official Site → |
Honest take: neither of the other two is a lesser choice — they're a different route to the same goal, and the right one depends on how far you want to go. If you qualify for prescription-strength medication and the price and process work for you, HumeCare+ is the most direct path to the drug class the trials in §2 are actually about. If a prescription and an injection aren't where you want to start, GLP-1 Plus's dihydroberberine route or MounjaBoost's lower-commitment format are both reasonable places to begin instead.
Full reviews: GLP-1 Plus · MounjaBoost
7. Pricing Options for HumeCare+
Your provider titrates the dose upward over the first several weeks — the same pattern the trials behind this drug class followed — so month one tells you how you tolerate it, not whether it's working. The 90-day results guarantee sits outside that window, for first-time GLP-1 users who complete it. Given all of that, budgeting for at least three months is the honest way to judge this membership before you decide to stay or cancel.
Semaglutide Injections
Monthly Membership
- Compounded semaglutide injections
- Provider evaluation & prescription
- Hume Pod smart scale
- 24/7 clinical support
Oral Semaglutide
Monthly Membership
- Compounded oral semaglutide
- Provider evaluation & prescription
- Hume Pod smart scale
- 24/7 clinical support
Tirzepatide + B12 + Glycine
Monthly Membership
- Compounded tirzepatide + B12 + glycine
- Provider evaluation & prescription
- Hume Pod smart scale
- 24/7 clinical support
Every plan starts with a free online evaluation — you only pay if a licensed clinician approves and writes a prescription. A separate, non-refundable consultation fee applies at enrollment and each refill; confirm the amount at checkout. The 90-Day Weight Loss Results Guarantee applies to first-time GLP-1 users who complete every weekly Hume Pod weigh-in and log every dose — see §7 of the price page for the complete conditions.
8. How the HumeCare+ Program Works
There's no supplement facts panel here, and no proprietary blend to decode. What you're evaluating is a process — application, evaluation, prescription, delivery — and a real drug at the end of it.
The path from application to your first dose:
- Apply online. A short health questionnaire, roughly 10 minutes, at no cost and no obligation.
- An independent Clinical Network reviews your case. A licensed U.S. clinician — not Hume itself — decides whether to prescribe; Hume states plainly it doesn't guarantee approval.
- If approved, your prescription goes to a licensed compounding pharmacy, which prepares the semaglutide or tirzepatide to that prescription.
- Medication ships free and discreetly, usually the next day, with the Hume Pod smart scale included on your first order.
- You log doses and weigh-ins in the Hume Care app; refills are automatic, and each one carries its own consultation fee.
What these terms actually mean:
- Compounded medication
- Prepared by a licensed pharmacy to an individual prescription, rather than manufactured and packaged by the original drug maker (Novo Nordisk for semaglutide, Eli Lilly for tirzepatide). It's legal and common when a drug is customized or in short supply — but the FDA has not reviewed the compounded version for safety, efficacy, or manufacturing quality the way it reviews the brand.
- GLP-1
- A hormone your gut releases after eating that tells your brain you're full and slows how fast your stomach empties. Semaglutide and tirzepatide are lab-made versions of it (tirzepatide also mimics a second hormone, GIP).
- Clinical Network
- The independent group of licensed U.S. prescribers who actually evaluate you and write the prescription. Hume Health Care LLC describes itself in its own Terms as a technology and administrative platform — it does not provide medical advice or clinical services.
What Ships to Your Door
No ingredient list, because there isn't one to disclose — this is a prescription, not a supplement label. Here's what a membership actually includes:
| Item | What it is |
|---|---|
| Your medication | Compounded semaglutide (injectable, 10 mg/2 mL concentration, or oral) or compounded tirzepatide (10 mg/2 mL) with added B12 and glycine — your prescriber sets the actual dose |
| Hume Pod | A smart scale that tracks weight and body composition; the 13 weekly weigh-ins it records are also what the results guarantee requires |
| Hume Care app | Where you log every dose and message the clinical team |
| Consultation | A provider review at enrollment and at every refill, billed as a separate, non-refundable fee not published on the site |
Results Timeline
HumeCare+ publishes its own curve on its homepage. Here's that curve, alongside what the trial data behind the drug class actually measured — on the brand-name formulation, not the compounded one.
| Timeframe | What HumeCare+ says to expect | Research context |
|---|---|---|
| 0–3 months | 5–10% of body weight, per the company's own program materials | Roughly tracks the pace early responders showed in STEP 1 and SURMOUNT-1, though those trials measured the FDA-approved brand |
| 3–6 months | 10–20% | Mid-trial figures in the same studies landed in a similar range at comparable doses |
| 6–12+ months | Maintenance | Both trials ran on the branded drug well past a year; long-term data on compounded formulations specifically is thinner |
Take the company's own curve as a plan, not a promise — it's not an independently verified figure for this specific compounded product, and STEP 1 measured its results over 68 weeks of continued treatment, not 90 days.
9. Side Effects & Safety
This is a real medication, not a supplement, and it comes with a real safety profile — including trade-offs the marketing pages don't dwell on. Your prescriber reviews your history before approving you, and the table below covers what to expect and what's serious enough to call about.
Possible Side Effects
| Side effect | Likelihood | What to do |
|---|---|---|
| Nausea | Common, especially as the dose increases | Usually eases as your provider titrates upward; smaller meals help. |
| Diarrhea, constipation, or stomach upset | Occasional | Typically resolves within the first few weeks after a dose change; tell your prescriber if it doesn't. |
| Injection site redness (injectable plans only) | Occasional | Rotate injection sites; contact your provider if swelling persists. |
| Gallbladder problems | Rare | Report sudden pain in the upper right abdomen promptly. |
| Pancreatitis | Rare | Seek care for severe abdominal pain that doesn't resolve. |
| Thyroid C-cell tumors | Not established in humans; seen in rodent studies of this drug class | This is why the label carries an FDA-mandated warning, and why a personal or family history of medullary thyroid carcinoma or MEN2 rules the medication out entirely. |
Check With Your Doctor First If…
Your intake evaluation is built to catch all of this, but it moves faster — and more safely — if you already know where you stand on:
- A personal or family history of medullary thyroid carcinoma or MEN2 — this is a hard contraindication, not a caution.
- A history of pancreatitis or gallbladder disease.
- Pregnancy, breastfeeding, or trying to conceive.
- Insulin or other diabetes medication you're currently taking.
- A previous serious reaction to a GLP-1 or GIP medication.
A licensed clinician reviews all of this at intake either way — the list above is what to have ready so that review goes faster, not a set of boxes you need to check yourself before applying. Full breakdown of what buyers report once they're on the medication: HumeCare+ Pros & Cons →
10. Final Verdict
How this applies to you. You've priced Ozempic at the pharmacy counter and put the bottle back. You've read three different weight-loss forums at midnight, trying to work out which telehealth site is real and which one is a script mill with a nice landing page. You've done the calorie math for the hundredth time and know, cell-deep, that math alone hasn't been the problem in years.
Those three moments are really one problem: real GLP-1 medication has been priced and gatekept out of reach for most people who'd benefit from it, and the alternative you can find on your own is either a supplement pretending to be a GLP-1 drug or an anonymous online pharmacy with no name attached to the prescription. HumeCare+'s actual offer sits between those two — a licensed U.S. Clinical Network reviews your case, prescribes real compounded semaglutide or tirzepatide when it's appropriate, and a licensed compounding pharmacy fills it, all under one $199–$299 monthly membership instead of a four-figure vial.
Your provider titrates the dose upward over the first several weeks, the same pattern the semaglutide and tirzepatide trials followed — so one month tells you how your body tolerates the medication, not whether it's working for you. The 90-day guarantee sits outside that: if you're a first-time GLP-1 user, log every dose, and complete your Hume Pod weigh-ins, the downside is Hume's to carry, not yours, if the number on the scale doesn't move. Given all of that, budgeting for at least three months before you judge the result is the honest way to use this membership — and starting the application costs nothing but the ten minutes it takes to find out if you qualify.
11. Frequently Asked Questions
Is HumeCare+ legit, or is this a script mill?
It's a real telehealth structure, not an anonymous pill mill: an independent Clinical Network of licensed U.S. prescribers evaluates you, and Hume Health Care LLC describes itself as the technology and administrative platform behind that process — not the one practicing medicine. Hume also says plainly it doesn't guarantee you'll be prescribed anything, which is the opposite of how a script mill operates.
Do I need insurance for HumeCare+?
No, and you can't use it here — the program is self-pay only, and doesn't accept insurance, Medicare or Medicaid. The $199 or $299 monthly membership is what you'd pay out of pocket either way, and it comes in well under the retail price of the brand-name injectable, which is rarely covered by insurance for weight loss alone.
Is compounded semaglutide the same as Ozempic?
No. Ozempic and Wegovy are the FDA-approved brand-name versions, manufactured by Novo Nordisk. Compounded semaglutide is prepared by a licensed pharmacy to your individual prescription, and the FDA has not reviewed it for safety, efficacy or manufacturing quality the way it reviewed the brand. It's the same active ingredient, made and regulated differently.
What happens if I don't qualify?
If the Clinical Network's initial evaluation finds you're not eligible, HumeCare+ says the membership fee refunds automatically within 10 business days — conditioned on returning the Hume Pod, in its original packaging, if one was sent. That's the one refund scenario the Terms describe as automatic, separate from the 90-day results guarantee.
Does the tirzepatide plan actually help with muscle loss?
The B12 and glycine addition is aimed at that concern, but it isn't a proven fix on its own — the research (Neeland 2024, Prado 2024) documents lean-tissue loss as a real trade-off of GLP-1-driven weight loss, not a solved problem. Staying active during treatment is the part with the clearer evidence behind it, regardless of which plan you're on.
What happens if I want to cancel?
Cancel any time through the app or by email, at least 48 hours before your next renewal date to avoid being charged. There's no prorated refund for a partially used period, and a prepaid plan keeps you enrolled through the end of its term without a refund on the unused portion.
PROGRAM TAGS
FORMAT
Research & Transparency
This content is based on publicly available clinical trial data, FDA and CDC publications, and HumeCare+'s own Terms of Service and program materials. We are not affiliated with Hume Health Care LLC. Marketing claims not supported by the company's own Terms are not repeated here.
(a) Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). N Engl J Med 2021
(b) Weight Regain and Cardiometabolic Effects after Withdrawal of Semaglutide (STEP 1 Extension). Diabetes Obes Metab 2022
(c) Changes in Lean Body Mass with GLP-1-Based Therapies and Mitigation Strategies. Diabetes Obes Metab 2024
(d) Muscle Matters: the Effects of Medically Induced Weight Loss on Skeletal Muscle. Lancet Diabetes Endocrinol 2024
(e) Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). N Engl J Med 2022
(f) FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss. FDA.gov
(g) Adult Obesity Facts. CDC.gov 2024
About the Author
Luciano Andreoti is a contributor at The Supplement Post, supporting the production of evidence-aware supplement and wellness-program reviews across multiple health categories. His work spans ingredient and program analysis, formulation and process assessment, and consumer-oriented summaries — what a company discloses, how its stated terms compare with what it actually publishes, and whether the offer matches what it claims to do. Every review is checked by The Supplement Post editorial team against the standards published in our editorial policy before it goes live.
Disclosure
All content is for informational purposes only and is not a substitute for professional medical advice. The program reviewed here dispenses a prescription medication only after an independent clinical evaluation — it is not a dietary supplement, and approval is not guaranteed. Results may vary based on individual health status and consistency of use. This page may contain affiliate links — if you purchase through them, we may earn a small commission at no additional cost to you. Read our Editorial Policy.